It's not a pump. The stock is going to have a viable market in Japan quickly and we have 2 trials that could lead to massive revaluation in the stock. Investors are starting to realize that the optionality of its stroke and UC outcomes is worth a heck of a lot more than $2.00. Oh, and between their cash and milestone payments I believe we can get through the key data points with little or no dilution.
I'll be the first to say it: in some ways, that has been the trading action, although I wouldn't necessarily call it a "pump". Here's the dilemma though: can you *really* be good enough to trade this and not miss the run, that many of us are expecting? Are that that good of a trader? Frankly, it looks so easy, although the few times I've really tried to trade in and out of a security- or "sell and then buy at a lower price"- I lost. Sometimes big. So I've learned my lesson(for the most part) and have stopped trying: I'm just not that good to be that greedy.